As the nation’s largest biopharma cluster, Boston has a proven track record of life science leadership, including emerging therapeutics. Digital technologies will play a critical role in the expansion of this industry poised to grow more than $350 billion in the next five years. Great progress has been made, but significant scientific, technological, financial, and regulatory challenges remain. We’ll take a closer look at what’s been accomplished and address how to handle the hurdles that lie ahead.
Learn what's fueling Boston's biotech investment and partnership opportunities by registering your team to attend Xcelerating Life Sciences: Biopharma’s Future in Digital Health
- April 29, 2020 at the Takeda Pharmaceuticals facility.
The Xcelerating Life Sciences event series convenes local communities of life science and technology innovators, executives, rising pioneers, entrepreneurs, investors, and scientists. Strategically positioned within six key life science hubs, each event is dedicated to helping industry leaders develop meaningful partnerships, spark inspiration, and explore bold new ideas to overcome healthcare’s biggest challenges.
Sign up for alerts about this event, including registration, speaker, and agenda announcements.